Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Elution Profile and Minimum Inhibitory Concentration of Antibiotic-loaded Cement After Primary Total Knee Arthroplasty

NCT05429671 is registered in ClinicalTrials.gov with Rothman Institute Orthopaedics as lead sponsor.

NCT NCT05429671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05429671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Elution Profile and Minimum Inhibitory Concentration of Antibiotic-loaded Cement After Primary Total Knee Arthroplasty
Lead sponsor
Rothman Institute Orthopaedics
Phase
Phase 3
Overall status
Completed
Start date
June 20, 2022
Completion date
November 30, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

total knee arthoplasty